Back

Comparison of NT-ProBNP levels in different groups of chronic heart failure: preliminary data analysis of research

13 May 2024 (15:40 - 17:00)
Organised by: Logo
Congress Presentation Part of: ePosters in acute heart failure 11 Biomarkers HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Vazgen Kalantaryan

Yerevan State Medical University, Yerevan (Armenia)

5 More presentations in this session

Presentation thumbnail
Exploring bioelectrical phase angle as a biomarker in heart failure patients
Doctor B. Braganca (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Lipoprotein A and the risk of developing left ventricle systolic dysfunction in the immediate post-acute coronary syndrome period.
Assistant Professor I. Rodean (Targu Mures, RO)
Abstract Slides Video
Presentation thumbnail
ID and high estimated plasma volume status in heart failure patients
Professor A. Safarova (Baku, AZ)
Abstract Slides Video
Presentation thumbnail
Non-invasive bioimpedance analysis predicts NT-proBNP changes during hospitalization in a cohort of acutely decompensated heart failure patients
Mr A. Herrmann (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
In-hospital bioimpedance-derived total body water predicts short-term cardiovascular mortality and re-hospitalizations in acute decompensated heart failure patients.
Doctor A. Faragli (Berlin, DE)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in acute heart failure 11

The Event

Event poster

Heart Failure 2024

13 May 2024 15:40 CET
You may be interested in
thumbnail
Congress Presentation
Clinical Implications of NT-proBNP trajectory following Sacubitril/Valsartan initiation
thumbnail
Congress Presentation
Prognosis and NT-proBNP decrease in heart failure patients from admission to follow up
thumbnail
Congress Presentation
Early increase and subsequent decrease in mature BNP and early decrease and continued decrease in proBNP after sacubitril/valsartan may relate to left ventricular reverse remodeling in heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources